Sort
17,054 grants matching “genome editing”
The Mechanism Of Beta-globin Gene Silencing In Embryonic-fetal Erythroid Cells: Application to Gene Therapy
$464,033Griffin P. Rodgers · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2021 · DK
Genome sequencing for evaluating the efficacy, specificity, and safety of human genome editing
$464,025David H Spencer · Washington University · U01 · FY2023 · AI
Cooperative role of TET2 and IDH2 mutations in angioimmunoblastic T-cell lymphomagenesis
$463,981Javeed Iqbal · University Of Nebraska Medical Center · R01 · FY2024 · CA
Developing newly combined therapeutic strategies for mature B cell lymphoma
$463,626Jing Hong Wang · University Of Colorado Denver · R01 · FY2020 · CA
Molecular functions of the shelterin component ACD/TPP1 in somatic stem cells and tissue homeostasis
$463,619Catherine Elizabeth Keegan · University Of Michigan At Ann Arbor · R01 · FY2019 · AG
Molecular functions of the shelterin component ACD/TPP1 in somatic stem cells and tissue homeostasis
$463,619Ivan Maillard · University Of Michigan At Ann Arbor · R01 · FY2016 · AG
Molecular functions of the shelterin component ACD/TPP1 in somatic stem cells and tissue homeostasis
$463,619Catherine Elizabeth Keegan · University Of Michigan At Ann Arbor · R01 · FY2018 · AG
Molecular functions of the shelterin component ACD/TPP1 in somatic stem cells and tissue homeostasis
$463,619Catherine Elizabeth Keegan · University Of Michigan At Ann Arbor · R01 · FY2017 · AG
Molecular functions of the shelterin component ACD/TPP1 in somatic stem cells and tissue homeostasis
$463,619Ivan Maillard · University Of Michigan At Ann Arbor · R01 · FY2015 · AG
Modeling p63-associated human birth defects with systems developmental biology approaches
$463,600Rui Yi · Northwestern University At Chicago · R01 · FY2025 · HD
Modeling p63-associated human birth defects with systems developmental biology approaches
$463,600Rui Yi · Northwestern University At Chicago · R01 · FY2023 · HD
Identifying metabolic dependencies in genetic subtypes of KRAS-driven lung cancer
$463,583Thales Papagiannakopoulos · New York University School Of Medicine · R37 · FY2023 · CA
Mobile DNA in Drug Abuse
$463,414Wade H Berrettini · University Of Pennsylvania · R01 · FY2016 · DA
Modeling Alzheimerâs disease using directly reprogrammed isogenic neural cells
$463,390Yanhong Shi · Beckman Research Institute/City Of Hope · R01 · FY2017 · AG
Characterization of the cellular and molecular bases of inborn errors of immunity
$463,347Luigi Notarangelo · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
Damage-Associated Molecular Patterns Driving Fibrosis Progression in Scleroderma
$463,297John Varga · University Of Michigan At Ann Arbor · R01 · FY2021 · AR
Extracellular Vesicle-Mediated Immunomodulation in HIV Infection and Nicotine Abuse
$463,289Kenneth W Witwer · Johns Hopkins University · R01 · FY2016 · DA
REGULATORS OF EPIDERMAL GENE EXPRESSION
$463,137Paul A Khavari · Stanford University · R01 · FY2022 · AR
Modeling p63-associated human birth defects with systems developmental biology approaches
$463,032Rui Yi · Northwestern University At Chicago · R01 · FY2022 · HD
CLL clonal evolution and the development of therapy-driven resistance
$463,019Catherine Ju-Ying Wu · Dana-Farber Cancer Inst · P01 · FY2016 · CA
Clinical and Translational Research Support Core for Institution # 269291
$462,989Brian Wigdahl · Temple Univ Of The Commonwealth · P30 · FY2023 · MH
Clinical and Translational Research Support Core for Institution # 269291
$462,989Brian Wigdahl · Temple Univ Of The Commonwealth · P30 · FY2025 · MH
Critical role of TCF-1 on the epigenetic identity of memory T cells
$462,689Golnaz Vahedi · University Of Pennsylvania · R01 · FY2020 · HL
Causes and Consequences of Whole Genome Duplication in Cancer Progression and Acquired Drug Resistance
$462,570Sergi Regot · Johns Hopkins University · R01 · FY2025 · CA
Identification of Genetic Factors Associated with Infectious Diseases
$462,474Cheryl Winkler · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA